Apogee Therapeutics, Inc. · NASDAQ:APGE

Henderson Michael Thomas sold 20,000 Apogee Therapeutics, Inc. shares (Form 4)

Traded Apr 8, 2026 · Filed Apr 10, 2026

On Apr 8, 2026, Henderson Michael Thomas (Director, Chief Executive Officer) sold 20,000 Apogee Therapeutics, Inc. shares at an average US$82.58 for US$1.65M under a trading plan, leaving 1,132,987 shares. Filed Apr 10, 2026 (Form 4).

Sold
20,000 shares
Price
US$82.58 average (US$82.48 to US$85.00)
Value
US$1.65M
Holding after
1,132,987 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 8, 2026Common StockSale17,800US$82.481,135,187Direct
Apr 8, 2026Common StockSale2,000US$83.261,133,187Direct
Apr 8, 2026Common StockSale200US$85.001,132,987Direct

Source

View original at SEC

Related